FDA Approves CAR T-Cell Therapy for Leukemia

• by John Gever John Gever,Managing Editor, MedPage Today August 30, 2017

WASHINGTON — The FDA on Wednesday approved a chimeric antigen receptor (CAR) T-cell therapy for treatment of certain pediatric and youthfull adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Read More